Clinical Trials Directory

Trials / Completed

CompletedNCT00367146

MMF After Pediatric Liver Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Hannover Medical School · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The use of CNIs (CSA or FK) as primary immunosuppressive drugs after pediatric liver transplantation is one of the main causes of chronic kidney disease in these patients in the long term. The study objective is the evaluation of safety of a modification in immunosuppression from a dual-immunosuppression (CSA or FK plus steroids) to a triple immunosuppression (MMF plus CSA (reduced dosage) plus steroids.

Conditions

Interventions

TypeNameDescription
DRUGMMF

Timeline

Start date
2004-11-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2006-08-22
Last updated
2011-05-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00367146. Inclusion in this directory is not an endorsement.